COMPANY PROFILE

Fenix Pharma, Italy’s first pharmaceu7cal coopera7ve, was established in 2011 by a group of former employees aBer a mul7na7onal’s departure from Europe leB hundreds jobless. Founded on resilience and solidarity, Fenix Pharma has grown into a mission-driven company specializing in pharmaceu7cals, nutraceu7cals, medical devices, and high-quality dermocosme7cs across areas like musculoskeletal, gastroenterology, ENT, and urogynecology, all adhering to strict GMP standards. In 2023, Fenix expanded into oncology through the acquisi7on of Wave Pharma, which focuses on breast cancer treatment.
The coopera7ve structure priori7zes employee empowerment, offering welfare programs, profit-sharing, and gender equality cer7fica7on, fostering a culture where every voice maQers. Fenix Pharma is also ac7ve in outlicensing its products in Europe and the Asia-Pacific markets and drives digitaliza7on to enhance efficiency and reduce opera7onal risks. With a team of over 100, Fenix Pharma’s values of transparency, collabora7on, and integrity shape its success and commitment to delivering innova7ve, high-quality healthcare solu7ons.